The SCARLET trial: a prospective phase II study of somatostatin receptor imaging for potential radiotheranostic application in patients with relapsing and refractory multiple myeloma.

Auteurs

Delbart W, Karfis I, Vercruyssen M, De Wind R, Meuleman N, Wimana Z, Flamen P, Woff E

  • Date de publication

    August 2025

  • Type

    Article

  • Review

    Eur J Nucl Med Mol Imaging

  • Researcher's name

    FLAMEN PATRICK

  • Hôpital

    Institut Jules Bordet

  • Service

    Médecine nucléaire IJB

  • PMID

    40866646

  • DOI

    10.1007/s00259-025-07500-y